Do prior neurological comorbidities predict COVID-19 severity and death? A 25-month cross-sectional multicenter study on 7370 patients.

Advanced Search

Mojtaba Sharafkhah, Farah Moayedi, Nozhan Alimi, Zeinab Haghighi Fini, Mohsen Ebrahimi-Monfared, Ali Massoudifar

Author Information

Mojtaba Sharafkhah: Department of Neurology and Psychiatry, School of Medicine, Arak University of Medical Sciences, Arak, Iran. ORCID
Farah Moayedi: Department of Psychiatry, Faculty of Medicine, Hormozgan University of Medical Sciences, 3817876137, Bandar Abbas, Iran.
Nozhan Alimi: Department of Psychiatry, Faculty of Medicine, Hormozgan University of Medical Sciences, 3817876137, Bandar Abbas, Iran.
Zeinab Haghighi Fini: Department of Psychiatry, Faculty of Medicine, Hormozgan University of Medical Sciences, 3817876137, Bandar Abbas, Iran.
Mohsen Ebrahimi-Monfared: Department of Neurology, School of Medicine, Arak University of Medical Sciences, Arak, Iran.
Ali Massoudifar: Department of Psychiatry, Faculty of Medicine, Hormozgan University of Medical Sciences, 3817876137, Bandar Abbas, Iran. Massoudifar_ali@yahoo.com.

PMID: 36522609 DOI: 10.1007/s13760-022-02152-3

BACKGROUND: The prognosis of COVID-19 cases that suffer from particular comorbidities is worse. The impact of chronic neurological disorders (CNDs) on the outcome of COVID-19 patients is not clear yet. This study aimed to assess whether CNDs can predict in-hospital mortality or severity in COVID-19 patients.
METHODS: Following a cross-sectional design, all consecutive hospitalized patients with PCR-confirmed COVID-19 who were hospitalized at three centers from February 20th, 2020 to March 20th, 2022, were studied. CND was defined as neurological conditions resulting in permanent disability. Data on demographic and clinical characteristics, COVID-19 severity, treatment, and laboratory findings were evaluated. A multivariate Cox-regression log-rank test was used to assess the primary outcome, which was in-hospital all-cause mortality. The relationship among CND, COVID-19 severity and abnormal laboratory findings was analyzed as a secondary endpoint.
RESULTS: We studied 7370 cases, 43.6% female, with a mean age of 58.7 years. 1654 (22.4%) patients had one or more CNDs. Patients with CNDs had higher age, were more disabled at baseline, and had more vascular risk factors and comorbidities. The ICU admission rate in CND patients with 59.7% was more frequent than the figure among non-CND patients with 20.3% (p = 0.044). Mortality of those with CND was 43.4%, in comparison with 12.8% in other participants (p = 0.005). Based on the Cox regression analysis, CND could independently predict death (HR 1.198, 95% CI 1.023-3.298, p = 0.003).
CONCLUSION: CNDs could independently predict the death and severity of COVID-19. Therefore, early diagnosis of COVID-19 should be considered in CND patients.

Death rate Neurological complications Prognostic factors SARS-CoV

Eybpoosh S, Afshari M, Haghdoost A-A, Kazerooni PA, Gouya MM, Tayeri K (2021) Severity and mortality of COVID-19 infection in HIV-infected individuals: preliminary findings from Iran. Med J Islam Repub Iran 35:33 [PMID: 34211935]
Organization. TWH. WHO Coronavirus (COVID-19) Dashboard Available online at: https://covid19.who.int/.2022
Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z et al (2020) Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 395(10229):1054–1062 [DOI: 10.1016/S0140-6736(20)30566-3]
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y et al (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395(10223):497–506 [DOI: 10.1016/S0140-6736(20)30183-5]
Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J et al (2020) Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 323(11):1061–1069 [DOI: 10.1001/jama.2020.1585]
Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y et al (2020) Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 395(10223):507–513 [DOI: 10.1016/S0140-6736(20)30211-7]
Guan W, Ni Z, Hu Y, Liang W, Ou C, He J et al (2020) Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 382(18):1708–1720 [DOI: 10.1056/NEJMoa2002032]
Wu C, Chen X, Cai Y, Zhou X, Xu S, Huang H et al (2020) Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med 180(7):934–943 [DOI: 10.1001/jamainternmed.2020.0994]
García-Azorín D, Martínez-Pías E, Trigo J, Hernández-Pérez I, Valle-Peñacoba G, Talavera B et al (2020) Neurological comorbidity is a predictor of death in covid-19 disease: a cohort study on 576 patients. Front Neurol 11:781 [DOI: 10.3389/fneur.2020.00781]
Psychiatry L (2020) Mental health and COVID-19: change the conversation. Lancet Psychiatry 7(6):463 [DOI: 10.1016/S2215-0366(20)30194-2]
Yao H, Chen J-H, Xu Y-F (2020) Patients with mental health disorders in the COVID-19 epidemic. Lancet Psychiatry 7(4):e21 [DOI: 10.1016/S2215-0366(20)30090-0]
Shinn AK, Viron M (2020) Perspectives on the COVID-19 pandemic and individuals with serious mental illness. J Clin Psychiatry 81(3):14205 [DOI: 10.4088/JCP.20com13412]
Herman C, Mayer K, Sarwal A (2020) Scoping review of prevalence of neurologic comorbidities in patients hospitalized for COVID-19. Neurology 95(2):77–84 [DOI: 10.1212/WNL.0000000000009673]
Aggarwal G, Lippi G, Michael HB (2020) Cerebrovascular disease is associated with an increased disease severity in patients with coronavirus disease 2019 (COVID-19): a pooled analysis of published literature. Int J Stroke 15(4):385–389 [DOI: 10.1177/1747493020921664]
Du R-H, Liang L-R, Yang C-Q, Wang W, Cao T-Z, Li M et al (2020) Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study. Eur Respir J 55(5):2000524 [DOI: 10.1183/13993003.00524-2020]
Farazmand A, Danaeefard H (2021) Iranian government’s responses to the coronavirus pandemic (COVID-19): an empirical analysis. Int J Public Adm 44(11–12):931–942 [DOI: 10.1080/01900692.2021.1903926]
Ghafari M, Hejazi B, Karshenas A, Dascalu S, Kadvidar A, Khosravi MA et al (2021) Lessons for preparedness and reasons for concern from the early COVID-19 epidemic in Iran. Epidemics 36:100472 [DOI: 10.1016/j.epidem.2021.100472]
Amiri S, Haghdoost A, Mostafavi E, Sharifi H, Peykari N, Raeisi A et al (2021) Iran COVID-19 epidemiology committee: A review of missions, structures, achievements, and challenges. J Res Health Sci 21(1):e00505 [DOI: 10.34172/jrhs.2021.45]
Nemani K, Li C, Olfson M, Blessing EM, Razavian N, Chen J et al (2021) Association of psychiatric disorders with mortality among patients with COVID-19. JAMA Psychiat 78(4):380–386 [DOI: 10.1001/jamapsychiatry.2020.4442]
Dua T, Janca A, Kale R, Montero F, Muscetta A, Peden M (2006) Public health, principles and neurological disorders. In: Aarli JA AG, Bertolote, JM dBH, Breivik H, Dua T, Graham N, Janca A, Kesselring J, Mathers C, MA, Prilipko L, Saraceno B, Saxena S, Steiner TJ (eds) World Health Organization: neurological disorders: public health challenges. World Health Organization, Geneva, pp 16–21
Quinn TJ, Dawson J, Walters MR, Lees KR (2009) Reliability of the modified Rankin Scale: a systematic review. Stroke 40(10):3393–3395 [DOI: 10.1161/STROKEAHA.109.557256]
Lega I, Nisticò L, Palmieri L, Caroppo E, Noce CL, Donfrancesco C et al (2021) Psychiatric disorders among hospitalized patients deceased with COVID-19 in Italy. EClinicalMedicine 35:100854 [DOI: 10.1016/j.eclinm.2021.100854]
Metlay JP, Waterer GW, Long AC, Anzueto A, Brozek J, Crothers K et al (2019) Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respiratory Crit Care Med 200(7):e45–e67 [DOI: 10.1164/rccm.201908-1581ST]
Force ADT, Ranieri V, Rubenfeld G, Thompson B, Ferguson N, Caldwell E et al (2012) Acute respiratory distress syndrome. JAMA 307(23):2526–2533
Zeidan AM, Boddu PC, Patnaik MM, Bewersdorf JP, Stahl M, Rampal RK et al (2020) Special considerations in the management of adult patients with acute leukaemias and myeloid neoplasms in the COVID-19 era: recommendations from a panel of international experts. Lancet Haematol 7(8):e601–e612 [DOI: 10.1016/S2352-3026(20)30205-2]
Asadi-Pooya AA, Simani L (2020) Central nervous system manifestations of COVID-19: a systematic review. J Neurol Sci 413:116832 [DOI: 10.1016/j.jns.2020.116832]
Helms J, Kremer S, Merdji H, Clere-Jehl R, Schenck M, Kummerlen C et al (2020) Neurologic features in severe SARS-CoV-2 infection. N Engl J Med 382(23):2268–2270 [DOI: 10.1056/NEJMc2008597]
Sanders JM, Monogue ML, Jodlowski TZ, Cutrell JB (2020) Pharmacologic treatments for coronavirus disease 2019 (COVID-19): a review. JAMA 323(18):1824–1836 [PMID: 32282022]
White DB, Lo B (2020) A framework for rationing ventilators and critical care beds during the COVID-19 pandemic. JAMA 323(18):1773–1774 [DOI: 10.1001/jama.2020.5046]
Harrison MF (2018) The misunderstood coagulopathy of liver disease: a review for the acute setting. Western J Emerg Med 19(5):863 [DOI: 10.5811/westjem.2018.7.37893]
Piano C, Di Stasio E, Primiano G, Janiri D, Luigetti M, Frisullo G et al (2020) An Italian neurology outpatient clinic facing SARS-CoV-2 pandemic: data from 2,167 patients. Front Neurol 11:564 [DOI: 10.3389/fneur.2020.00564]
Schwartz N, Sakhnini A, Bisharat N (2018) Predictive modeling of inpatient mortality in departments of internal medicine. Intern Emerg Med 13(2):205–211 [DOI: 10.1007/s11739-017-1784-8]
Smolin B, Levy Y, Sabbach-Cohen E, Levi L, Mashiach T (2015) Predicting mortality of elderly patients acutely admitted to the Department of Internal Medicine. Int J Clin Pract 69(4):501–508 [DOI: 10.1111/ijcp.12564]
Mao L, Jin H, Wang M, Hu Y, Chen S, He Q et al (2020) Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol 77(6):683–690 [DOI: 10.1001/jamaneurol.2020.1127]
Lopez Espuela F, Roncero-Martín R, Zamorano JDP, Rey-Sanchez P, Aliaga-Vera I, Portilla Cuenca JC et al (2019) Controlling Nutritional Status (CONUT) score as a predictor of all-cause mortality at 3 months in stroke patients. Biol Res Nurs 21(5):564–570 [DOI: 10.1177/1099800419860253]
Sahni AS, Wolfe L (2018) Respiratory care in neuromuscular diseases. Respir Care 63(5):601–608 [DOI: 10.4187/respcare.06210]
Rae-Grant AD, Turner AP, Sloan A, Miller D, Hunziker J, Haselkorn JK (2011) Self-management in neurological disorders: systematic review of the literature and potential interventions in multiple sclerosis care. J Rehabil Res Dev 48(9):1087 [DOI: 10.1682/JRRD.2010.08.0159]
Matías-Guiu J, Porta-Etessam J, Lopez-Valdes E, Garcia-Morales I, Guerrero-Solá A, Matias-Guiu J (2020) Management of neurological care during the COVID-19 pandemic. Neurología (Engl Ed) 35(4):233–237 [DOI: 10.1016/j.nrleng.2020.04.001]
Sirin S, Nigdelioglu Dolanbay S, Aslim B (2022) The relationship of early-and late-onset Alzheimer’s disease genes with COVID-19. J Neural Transm 16:1–3

Humans

Female

Middle Aged

Male

COVID-19

SARS-CoV-2

Cross-Sectional Studies

Comorbidity

Risk Factors

Nervous System Diseases

Multicenter Study Journal Article

No available data.

OpenLB
Open Library of Bioscience